We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+3.49%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$1.69M
(+1.5%)
Cap. Flow
-$86.1K
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
24.81%
Holding
128
New
10
Increased
15
Reduced
46
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CALL
magicJack VocalTec Ltd
CALL
|
+$1.04M |
| 2 |
MEMP
Memorial Production Partners LP Common Units
MEMP
|
+$987K |
| 3 |
Navigator Holdings
NVGS
|
+$984K |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$920K |
| 5 |
Itron
ITRI
|
+$903K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.85M |
| 2 |
AFOP
Alliance Fiber Optic Prod Inc
AFOP
|
+$1.59M |
| 3 |
Encore Capital Group
ECPG
|
+$1.58M |
| 4 |
AFFX
Affymetrix Inc
AFFX
|
+$1.29M |
| 5 |
EPIQ
EPIQ SYSTEMS INC
EPIQ
|
+$909K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.12% |
| 2 | Healthcare | 16.33% |
| 3 | Energy | 11.29% |
| 4 | Financials | 10.56% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1
Novo Nordisk
NVO
$208B
| $7.04M | 6.26% |
263,800
+800
| +0.3% | +$18.4K |
|
2
Microsoft
MSFT
$3.62T
| $3.36M | 2.99% |
82,694
-250
| -0.3% | -$10.9K |
|
3
Fidelity National Financial
FNF
$13.9B
| $2.69M | 2.39% |
105,410
-7,222
| -6% | -$182K |
|
4
Alphabet (Google) Class C
GOOG
$4.56T
| $2.52M | 2.24% |
91,531
+2,808
| +3% | +$75.2K |
|
5
Harvard Bioscience
HBIO
$28.5M
| $2.42M | 2.15% |
41,505
-1,690
| -4% | -$90.8K |
|
|
AFFX
6
DELISTED
Affymetrix Inc
AFFX
| $2.13M | 1.89% |
169,725
-111,050
| -40% | -$1.29M |
|
7
GE Aerospace
GE
$383B
| $2.04M | 1.81% |
17,148
+5,788
| +51% | +$689K |
|
|
XCRA
8
DELISTED
Xcerra Corporation
XCRA
| $1.96M | 1.74% |
220,451
| – | – |
|
|
PRCP
9
DELISTED
Perceptron Inc
PRCP
| $1.91M | 1.7% |
141,406
-2,100
| -1% | -$23.6K |
|
|
ESIO
10
DELISTED
Electro Scientific Industries
ESIO
| $1.86M | 1.66% |
301,835
-900
| -0.3% | -$6.08K |
|
11
Synopsys
SNPS
$75.1B
| $1.84M | 1.63% |
39,650
-1,650
| -4% | -$73.9K |
|
12
Data I/O
DAIO
$30.4M
| $1.82M | 1.61% |
490,700
-33,716
| -6% | -$111K |
|
13
Moody's
MCO
$83.7B
| $1.82M | 1.61% |
17,500
-1,400
| -7% | -$135K |
|
|
FEIC
14
DELISTED
FEI COMPANY
FEIC
| $1.76M | 1.56% |
23,035
-350
| -1% | -$28K |
|
|
EPAY
15
DELISTED
Bottomline Technologies Inc
EPAY
| $1.75M | 1.55% |
63,910
-2,800
| -4% | -$72.7K |
|
|
ARRS
16
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $1.63M | 1.45% |
56,367
-1,200
| -2% | -$34.1K |
|
17
Thomson Reuters
TRI
$44.4B
| $1.62M | 1.44% |
34,511
| – | – |
|
18
Targa Resources
TRGP
$56.8B
| $1.61M | 1.43% |
16,826
+4,426
| +36% | +$415K |
|
19
Immersion
IMMR
$248M
| $1.57M | 1.39% |
170,786
-550
| -0.3% | -$4.86K |
|
|
ZIXI
20
DELISTED
Zix Corporation
ZIXI
| $1.56M | 1.38% |
395,956
+235,400
| +147% | +$892K |
|
|
SHOR
21
DELISTED
ShoreTel, Inc.
SHOR
| $1.54M | 1.37% |
225,900
-8,000
| -3% | -$57.2K |
|
22
Verizon
VZ
$197B
| $1.54M | 1.37% |
31,638
+4,000
| +14% | +$193K |
|
23
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $1.51M | 1.34% |
7,315
+4,195
| +134% | +$866K |
|
24
First American
FAF
$7.7B
| $1.5M | 1.33% |
42,083
-1,400
| -3% | -$48.7K |
|
25
Kulicke & Soffa
KLIC
$4.72B
| $1.47M | 1.31% |
94,100
-2,700
| -3% | -$41.9K |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q1 2015 Portfolio in Review
As of Q1 2015, Penbrook Management held 128 positions worth $113M, up 1.5% from $111M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Penbrook Management's Q1 2015 filing shows 10 new, 15 increased, 46 reduced and 12 closed positions. Its largest new stake was magicJack VocalTec Ltd: 137,200 shares worth $938K. The largest sale was Allergan Inc, an estimated $1.85M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Energy.
- Penbrook Management's largest Q1 2015 buy was magicJack VocalTec Ltd: 137,200 shares worth $938K.
- Penbrook Management added most to Zix Corporation in Q1 2015, an estimated $892K increase.
- Penbrook Management's biggest Q1 2015 reduction was Affymetrix Inc, cutting an estimated $1.29M.
- Penbrook Management fully exited Allergan Inc in Q1 2015, selling an estimated $1.85M.
- Penbrook Management's ten largest holdings make up 25% of its $113M portfolio in Q1 2015.
- Penbrook Management opened 10 new positions and closed 12 in Q1 2015.
- Penbrook Management's portfolio value rose 1.5% quarter-over-quarter to $113M.
Based on Penbrook Management's 13F filing for Q1 2015, filed 27 Apr 2015.